{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":7,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":7,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"24ababab392c","filters":{"venue":"Current Drug Targets - CNS & Neurological Disorders"}},"results":[{"id":"W2072477505","doi":"10.2174/156800705774322058","title":"CREB, Synapses and Memory Disorders: Past Progress and Future Challenges","year":2005,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":186,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"CREB; Neuronal memory allocation; Neuroscience; Long-term potentiation; Aplysia; Synaptic plasticity; Transcription factor; Biology; Neuroplasticity; Cell biology; Metaplasticity; Gene; Genetics; Receptor","authors":[{"name":"Sheena A. Josselyn","is_ca":true},{"name":"Peter Nguyen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02189130959391541,"gpt":0.2922035506718325,"spread":0.2703122410779171,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000150548,0.0007275093,0.0008948765,0.0001082854,0.0002253683,0.00006590282,0.000253553,0.0005160359,0.00003781442],"category_scores_gemma":[0.00004247438,0.0005246637,0.000313792,0.0001102121,0.0005132327,0.00001538842,0.0003481672,0.0005059998,0.000006203861],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008534699,"about_ca_system_score_gemma":0.0000452376,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":9.31473e-7,"about_ca_topic_score_gemma":0.00003764775,"domain_scores_codex":[0.9973437,0.0003257704,0.0004621836,0.001187657,0.0001974849,0.0004832342],"domain_scores_gemma":[0.9990142,0.00005295574,0.0002777754,0.0003955627,0.00003630912,0.0002231734],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004175906,0.0002494747,0.0001582566,0.001667856,0.00007759262,0.000001713074,0.00005074612,0.000001297501,6.671118e-7,0.00005947931,0.001752447,0.9959387],"study_design_scores_gemma":[0.0003874967,0.0002949928,0.001014356,0.0002467938,0.0002160176,0.00002083578,0.00005057573,0.00001262856,6.782988e-7,0.000105552,0.9970731,0.0005770274],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001464368,0.9940754,0.00001139724,0.002172196,0.001030728,0.0009121101,0.0000586307,0.00006947874,0.0002056597],"genre_scores_gemma":[0.001324779,0.9963481,0.00003525723,0.0001209886,0.001194638,0.0002198188,0.0006150305,0.00005826277,0.000083076],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9953617,"threshold_uncertainty_score":0.9997205,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2112341182","doi":"10.2174/1568007023338914","title":"Galanin: A Biologically Active Peptide","year":2002,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":81,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Galanin; Galanin receptor; Neuropeptide; Internal medicine; Endocrinology; Biology; Central nervous system; Receptor; Medicine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.08688973407603384,"gpt":0.3283329591641141,"spread":0.2414432250880802,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0001477976,0.001688231,0.003093353,0.000312774,0.0004977173,0.0001383255,0.002258273,0.000533533,0.001623596],"category_scores_gemma":[0.001303943,0.001126796,0.001838405,0.0009665182,0.001050717,0.0002212773,0.001191193,0.003111457,0.003004911],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005146459,"about_ca_system_score_gemma":0.00008656336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003485885,"about_ca_topic_score_gemma":0.000002617261,"domain_scores_codex":[0.9912963,0.001816614,0.001299559,0.00322959,0.0005594894,0.001798484],"domain_scores_gemma":[0.9960076,0.001605307,0.0008928974,0.0009211348,0.00005057623,0.0005225333],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007673811,0.001187914,0.00001607947,0.001553607,0.00002985596,0.0001687488,0.00003461608,0.000004918779,0.0001758936,0.001042394,0.01013055,0.9855787],"study_design_scores_gemma":[0.0003104937,0.0007937648,0.00008616644,0.0005980842,0.0002052801,0.00005313531,0.00000364137,0.00003566603,0.000008839198,0.001620456,0.9951175,0.001167002],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009938393,0.9873151,0.000006421794,0.0001987414,0.001882161,0.002050548,0.0004450592,0.0007126846,0.006395478],"genre_scores_gemma":[0.002507116,0.9947104,0.00001854793,0.001176382,0.0004520009,0.0003715123,0.0001425095,0.0001514116,0.0004700737],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9849869,"threshold_uncertainty_score":0.9995865,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1987897200","doi":"10.2174/1568007053544183","title":"NMDA/NR2B Selective Antagonists in the Treatment of Ischemic Brain Injury","year":2005,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":62,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Ifenprodil; NMDA receptor; Neuroprotection; Glutamate receptor; Neuroscience; Medicine; Pharmacology; Receptor; Neurotransmission; Biology; Internal medicine","authors":[{"name":"Chen Wang","is_ca":true},{"name":"Ashfaq Shuaib","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09252142624873262,"gpt":0.4242557918291176,"spread":0.331734365580385,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004857919,0.001031425,0.001901596,0.0005928872,0.0003696539,0.00008585385,0.002343833,0.0002899324,0.0001280798],"category_scores_gemma":[0.0009087037,0.0006219958,0.0009186868,0.002342223,0.001473957,0.0002170534,0.0002953999,0.001972292,0.0001378479],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001049956,"about_ca_system_score_gemma":0.0003570098,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007013018,"about_ca_topic_score_gemma":0.00001175568,"domain_scores_codex":[0.9910498,0.003369684,0.001127068,0.002109305,0.0008960026,0.001448202],"domain_scores_gemma":[0.9951393,0.003235894,0.0005584544,0.000800362,0.00003802983,0.000227968],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001646286,0.004973446,0.0001569651,0.0006996481,0.00001461028,0.0001271473,0.0003945706,0.000008443203,0.001400305,0.0000685597,0.01130545,0.9806862],"study_design_scores_gemma":[0.0005774352,0.001475763,0.00006583672,0.0001405384,0.0001062643,0.00003410497,0.000008416461,0.00005022432,0.0007993217,0.00008689722,0.9961635,0.0004917144],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03172891,0.9597743,0.000001678296,0.002032486,0.001298763,0.004098876,0.0002987736,0.0001292629,0.0006369986],"genre_scores_gemma":[0.0139604,0.983643,0.000002172916,0.001181605,0.0001938426,0.000788225,0.00001946415,0.00006760839,0.0001436923],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.984858,"threshold_uncertainty_score":0.9996231,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2056349137","doi":"10.2174/1568007043337076","title":"Exercise in a Pill: Feasibility of Energy Expenditure Targets","year":2004,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Energy, Environment, and Transportation Policies","field":"Energy","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"","keywords":"Pill; Energy expenditure; Energy metabolism; Medicine; Pharmacology; Internal medicine","authors":[{"name":"Jean Himms‐Hagen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03501207138564143,"gpt":0.3033825570588669,"spread":0.2683704856732255,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002499037,0.001269355,0.002994594,0.0004834412,0.0001313627,0.00002913292,0.001021854,0.0006475057,0.0007464841],"category_scores_gemma":[0.0001074621,0.001017434,0.001349627,0.0006387839,0.0005971413,0.0001866536,0.0001719216,0.001130209,0.00003518873],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001312258,"about_ca_system_score_gemma":0.0001718622,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006627592,"about_ca_topic_score_gemma":0.001155286,"domain_scores_codex":[0.9942575,0.0005409899,0.001886098,0.001583516,0.0006601391,0.001071799],"domain_scores_gemma":[0.9974968,0.0002548412,0.0008676632,0.001012474,0.00003179981,0.0003363552],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000201176,0.006352276,0.002022705,0.01799866,0.0002083962,0.0001058115,0.00076267,0.01151253,0.000002065903,0.02979019,0.001089997,0.9299535],"study_design_scores_gemma":[0.000925631,0.0001166568,0.001822796,0.002630354,0.0003617633,0.000002393159,0.00002358822,0.00001603961,0.00000411394,0.008860978,0.9842913,0.0009443974],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006878824,0.9957781,0.00006710547,0.0001003501,0.00101871,0.0008077904,0.0002603655,0.0001756497,0.001103998],"genre_scores_gemma":[0.02425589,0.9732352,0.0000519055,0.00008172137,0.00008658247,0.0005045151,0.001538622,0.0001272506,0.0001183094],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9832013,"threshold_uncertainty_score":0.9992276,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1985778670","doi":"10.2174/156800705774322067","title":"Abeta Immunotherapy and Other Means to Remove Amyloid","year":2005,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Presenilin; Genetically modified mouse; Alzheimer's disease; Amyloid precursor protein; Transgene; Amyloid (mycology); Immunotherapy; Amyloid beta; Disease; Medicine; Chemistry; Immunology; Immune system; Biochemistry; Pathology","authors":[{"name":"Edith G. McGeer","is_ca":true},{"name":"Patrick L. McGeer","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05743566858691119,"gpt":0.3751797894650004,"spread":0.3177441208780892,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002263762,0.001042002,0.002244487,0.0003551986,0.0002141016,0.00007721113,0.000445177,0.0003018655,0.0009264797],"category_scores_gemma":[0.000141441,0.0006928463,0.0009234762,0.000484201,0.0003312946,0.00008444783,0.0002597606,0.001144196,0.0006384188],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008117101,"about_ca_system_score_gemma":0.0002432995,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002134038,"about_ca_topic_score_gemma":0.00001573438,"domain_scores_codex":[0.9955367,0.0004301796,0.0007567712,0.001406895,0.0007131325,0.001156296],"domain_scores_gemma":[0.9975241,0.0002579465,0.0002244241,0.0008339438,0.00006512614,0.001094401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002368228,0.001453681,0.0009374747,0.001239579,0.002327495,0.00006685419,0.00006561656,9.229443e-7,1.515722e-7,0.00005322493,0.003625127,0.989993],"study_design_scores_gemma":[0.001298201,0.0006156791,0.0007342917,0.001017825,0.001452831,0.00002973472,0.000007272005,0.0000183201,1.579617e-7,0.0001824264,0.9940816,0.000561629],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004265863,0.9930287,0.00001725504,0.001134473,0.0003262851,0.003297894,0.0003476525,0.0001917305,0.001229443],"genre_scores_gemma":[0.0003919659,0.9968982,0.000125503,0.001239505,0.0003074205,0.0004560798,0.0002997392,0.0001514208,0.0001301945],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9904565,"threshold_uncertainty_score":0.9999868,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2065097064","doi":"10.2174/1568007033338832","title":"Osteoporosis in Anorexia Nervosa: A Brittle Future","year":2003,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Eating Disorders and Behaviors","field":"Psychology","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Anorexia nervosa; Osteopenia; Osteoporosis; Medicine; Anorexia; Pediatrics; Endocrinology; Internal medicine; Eating disorders; Psychiatry; Bone mineral","authors":[{"name":"Debra K. Katzman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04091482381570872,"gpt":0.3522683560232328,"spread":0.3113535322075241,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0004324827,0.001484776,0.002928063,0.0005427951,0.000244118,0.0001022161,0.001239911,0.001071154,0.00378295],"category_scores_gemma":[0.00009895239,0.001183874,0.001448781,0.001446425,0.0003825855,0.0001158681,0.0002792576,0.003067511,0.0007596074],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006984414,"about_ca_system_score_gemma":0.0001441022,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009199131,"about_ca_topic_score_gemma":0.0002655451,"domain_scores_codex":[0.9924529,0.001550589,0.001574007,0.002241079,0.0005052299,0.001676163],"domain_scores_gemma":[0.9974229,0.0003240119,0.0006959764,0.001148386,0.00005202552,0.0003567482],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002802854,0.002692663,0.01158033,0.001460445,0.00005617394,0.0000840897,0.0004179261,0.00000210613,4.559242e-8,0.0003583838,0.03937967,0.9439401],"study_design_scores_gemma":[0.0008197089,0.0003306408,0.002526493,0.0006066572,0.0004636006,0.00002293833,0.0001738081,0.000002209582,4.444389e-9,0.0005329434,0.9933353,0.001185695],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002067363,0.9850322,0.000006252911,0.0002387525,0.006847963,0.002017893,0.000156716,0.0002614387,0.003371428],"genre_scores_gemma":[0.0002800923,0.9963837,0.00005386064,0.000351604,0.0003626489,0.001008294,0.0007297642,0.0001841708,0.0006458397],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9539557,"threshold_uncertainty_score":0.9997901,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2005425566","doi":"10.2174/156800705774322085","title":"Cholesterol and Apoe: A Target for Alzheimers Disease Therapeutics","year":2005,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Pathogenesis; Disease; Apolipoprotein E; Alzheimer's disease; Medicine; Cholesterol; Apolipoprotein B; Bioinformatics; Immunology; Internal medicine; Biology","authors":[{"name":"Daniela Fenili","is_ca":false},{"name":"JoAnne McLaurin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0708535222575065,"gpt":0.3655597761296528,"spread":0.2947062538721463,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005025479,0.001017601,0.00268326,0.0002144045,0.000263823,0.00006982905,0.0003579475,0.0003682233,0.00007956435],"category_scores_gemma":[0.0001524231,0.0007062929,0.002023655,0.000289147,0.0003236672,0.00009456018,0.0001933089,0.001228992,0.00003484786],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004992681,"about_ca_system_score_gemma":0.000367904,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004413042,"about_ca_topic_score_gemma":0.000003968717,"domain_scores_codex":[0.9956511,0.0003987001,0.0008937321,0.001422511,0.0006164943,0.00101752],"domain_scores_gemma":[0.9975373,0.0002023424,0.0003414415,0.000940348,0.00008212688,0.0008964433],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001140308,0.0005551063,0.0001075931,0.008288805,0.0005072811,0.000009228569,0.00002959975,0.000003223215,2.57412e-8,0.00007427851,0.001325762,0.9889851],"study_design_scores_gemma":[0.001574477,0.0004252409,0.0005591133,0.001082692,0.004950207,0.00002350451,0.000006402131,0.0001676471,6.613209e-8,0.0002345097,0.9903439,0.0006322993],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001824017,0.9901867,0.0003523927,0.001665203,0.0007802644,0.006227213,0.0003194195,0.0001937873,0.00009260602],"genre_scores_gemma":[0.0004482709,0.9946439,0.0002762159,0.001359213,0.0008523142,0.001372891,0.0008288443,0.0001534957,0.00006480492],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9890181,"threshold_uncertainty_score":0.9995388,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}